自然存在的植物化学物质以准乳腺癌细胞信号传递
Muttiah Barathan1, Kumutha Malar Vellasamy2, Vanitha Mariappan3
1Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Lembah Pantai, 50603, Kuala Lumpur, Malaysia. barathanmuttiah@um.edu.my.
Applied biochemistry and biotechnology
|September 29, 2023
概括
天然产品对于癌症治疗至关重要,提供针对乳腺癌的向机制. 纳米技术增强了这些天然化合物,改善了药物输送和晚期癌症患者的治疗结果.
科学领域:
- 瘤学和天然产品化学
- 药理学和纳米医学的研究.
背景情况:
- 天然产品占抗瘤药物的近70%,表现出各种抗癌机制,如诱导亡和细胞循环抑制.
- 来自自然来源的植物化学物质在调节瘤途径和与乳腺癌相关的瘤抑制剂方面发挥着重要作用.
- 目前的乳腺癌治疗方法存在局限性,这凸显出需要新的治疗策略.
研究的目的:
- 审查当前的乳腺癌治疗方法及其相关的缺点.
- 探索自然存在的植物化学物质在乳腺癌中诱导亡的机制.
- 评估纳米技术在提高抗癌药物的疗效方面的贡献.
主要方法:
- 对癌症治疗中天然产品现有研究的文献综述.
- 分析植物化学物质在各种乳腺癌类型中诱导亡的机制.
- 纳米技术应用在改善抗癌药物输送和有效性方面的评估.
主要成果:
- 自然产品及其衍生物在诱导癌细胞选择性细胞毒性,抗转移和亡方面是有效的.
- 植物化学物质在调节乳腺癌进展至关重要的信号通路方面具有显著的潜力.
- 纳米技术为基于天然产品的抗癌治疗提供了增强的向传递,改善的生物可用性和组合治疗选择.
结论:
- 天然产品仍然是开发新型乳腺癌化学预防药物的重要来源,特别是对于晚期的乳腺癌.
- 将纳米技术与天然产品衍生的化合物相结合,有望克服传统疗法的局限性.
- 对天然产品和纳米医学的持续研究对于推进乳腺癌治疗和提高患者存活率至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K